SCHEMBL21160642

SCHEMBL21160642

Cn1c2ccc(CN)cc2c2c3c(c4c(c21)CCC4)C(=O)NC3=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 9/20 0.58
▸ MYLK Q15746 4/20 0.41
▸ CDK4 P11802 4/20 0.41
▸ CCND1 P24385 4/20 0.41
▸ PRKACA P17612 2/20 0.39
▸ PRKACG P22612 2/20 0.39
▸ PRKACB P22694 2/20 0.39
▸ CCNE2 O96020 1/20 0.39
▸ CCNE1 P24864 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ PRKCB P05771 2/20 0.38
▸ PRKCA P17252 2/20 0.38
▸ PRKD3 O94806 1/20 0.38
▸ PRKCG P05129 1/20 0.38
▸ PRKCH P24723 1/20 0.38
▸ PRKCI P41743 1/20 0.38
▸ PRKCE Q02156 1/20 0.38
▸ PRKCQ Q04759 1/20 0.38
▸ PRKCZ Q05513 1/20 0.38
▸ PRKCD Q05655 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21155204 0.87 PARP1 (0.56) PARP1CDK4CCND1PRKCBPRKCA
SCHEMBL29435084 0.74 PARP1 (1.00) PARP1
SCHEMBL12256417 0.74 PARP1 (1.00) PARP1
SCHEMBL21160075 0.67 PARP1 (0.38) PARP1CDK4CCND1
SCHEMBL8112495 0.64 CDK4 (0.72) MYLKCDK4CCND1PRKACAPRKACG
Hydrochloric Acid SCHEMBL30379478 0.63 NQO2 (0.54) PRKCBPRKCA
SCHEMBL21160645 0.62 PARP1 (0.74) PARP1
SCHEMBL8122531 0.60 MYLK (0.72) MYLKCDK4CCND1PRKACAPRKACG
SCHEMBL21155625 0.60 PARP1 (0.70) PARP1
SCHEMBL8121899 0.60 MYLK (0.68) MYLKCDK4CCND1PRKACAPRKACG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019136298-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES Cybrexa, Inc. (US) 2019-07-11 — — WO disclosed
Send feedback